Across four prospective U.S. cohorts, 4.5% of those 18-49 years old met criteria for COPD, defined as spirometric airflow ...

For patients with heart failure and severe mitral regurgitation (MR) undergoing transcatheter edge-to-edge repair (M ...

Left-sided heart failure is a kind of cardiovascular disorder that primarily impacts the lungs. Consult a doctor if you ...

Heart failure patients living in the most deprived postcodes are at risk of dying six and a half months earlier than patients ...

The FDA has approved Kerendia® (finerenone) to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits.

New research from Emory University reveals that even seemingly small lifestyle improvements decreased one’s risk of ...

Following priority review, the FDA approved Kerendia for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.

Patients with COPD and type 2 diabetes had a reduced risk for COPD hospitalization, noninvasive positive-pressure ventilation and all-cause mortality if they used an SGLT-2 inhibitor, according to ...

Findings show even stronger association for more vulnerable older adults. (HealthDay News) — Wildfire smoke exposure over time may increase the risk for heart failure, according to a study ...

Research shows heart attack deaths have plummeted by nearly 90% since 1970, while deaths from heart failure and arrhythmias have increased, highlighting new cardiovascular challenges.

Your chance of dying from a heart attack has dropped dramatically, but other deadly heart conditions are on the rise, a new study found.

Deaths from heart attacks have plummeted in the US over the past 50 years, whereas deaths from chronic heart conditions have skyrocketed, probably due to people living longer. “We’ve made some ...